Name: Allogeneic Stem Cells Market Size, Share, Industry, Forecast and outlook (2024-2031)
Brand: DataM Intelligence
SKU: BT4054
Price: 4350 USD
Availability: InStock

Allogeneic Stem Cells Market Size Share Report And Forecast 2024-2031

Allogeneic Stem Cells Market Size, Share, Industry, Forecast and outlook (2024-2031)

<h2>Global Allogeneic Stem Cells Market is segmented By Product (Progesterone Oral, Progesterone Injection, Progesterone Suspended/Gel, Others), By Application (Hospital, Clinic, Pharmacies, and Drug Stores)By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h2>&nbsp;</h2>

<h3>Allogeneic Stem Cells Market&nbsp;Overview</h3>

<blockquote>
The Global Allogeneic Stem Cells Market size reached USD 0.9 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 2.0 billion by 2031. The global allogeneic stem cells market is expected to exhibit a CAGR of 9.6% during the forecast period (2024-2031).
</blockquote>

&nbsp;

&nbsp;The allogeneic stem cells market experiencing significant growth in recent years. Conditioning treatment is given before an allogeneic stem cells transplant to destroy any remaining cancer cells in the body. This weakens the patient&#39;s immune system and allows the new cells to move through the bloodstream to the patient&#39;s bone marrow. For some types of blood cancers, an allogeneic stem cell transplant may work directly to destroy cancer cells, known as the graft-versus-tumor (GVT) effect.&nbsp;

The global allogeneic stem cells market is driven by the factors such as the increasing prevalence of cardiovascular disorders, cancer diseases, and other chronic disorders, increasing awareness and acceptance of stem cell therapies, increasing research and development activities on allogeneic stem cells, rising demand for regenerative medicines, and technological advancements in allogeneic stem cell transplantation.

<h2>&nbsp;</h2>

<h3>Allogeneic Stem Cells Market&nbsp; Scope</h3>

<table cellspacing="0" style="border-collapse:collapse; width:624px">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #8eaadb; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			9.6%
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Size Available for Years
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Data Availability
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$)
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Product, Cell Origin, and Application
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d6e6f4; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Infection Type Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis, and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

<h3>To know more Insights - &nbsp;<a href="https://www.datamintelligence.com/download-sample/allogeneic-stem-cells-market">Download Sample</a>&nbsp;</h3>

<h2>&nbsp;</h2>

<h3>Allogeneic Stem Cells Market&nbsp; Dynamics</h3>

Rising Demand for Regenerative Medicines Drives the Growth of the Allogeneic Stem Cells Market

The allogeneic stem cells market is experiencing substantial growth due to the rising demand for regenerative medicines. Regenerative medicine focuses on repairing or replacing damaged tissues and organs through the use of stem cells, among other advanced therapies. Allogeneic stem cells, obtained from a donor, offer several advantages in regenerative medicine applications.

Moreover, the aging population and the associated rise in age-related diseases have further fueled the demand for regenerative medicines. Allogeneic stem cell therapies offer the possibility of restoring function and improving the quality of life for patients suffering from degenerative conditions.

For instance, on September 20, 2022, Alkem Laboratories, in collaboration with Stempeutics, launched the first &lsquo;made-in India&rsquo; off-the-shelf cell therapy product &ldquo;StemOne&rdquo; to treat Knee Osteoarthritis. The company announced that it received regulatory approval from the Drugs Controller General of India (DCGI) for the product. It is the first allogeneic cell therapy product to be approved for commercial use in India for Knee Osteoarthritis.

Increasing Awareness and Acceptance of Stem Cells Therapies Drive the Growth of the Market

The increasing awareness about allogeneic stem cells and their wide acceptance boosts the market share. High-profile media coverage of successful stem cell treatments and patient testimonials have helped raise awareness about the transformative potential of stem cell therapies. Positive outcomes and stories of patients who have experienced significant improvements in their conditions have captured public attention and fostered acceptance.

As awareness and acceptance of stem cell therapies continue to increase, more patients and healthcare providers are considering these treatments as viable options. This growing demand and acceptance have stimulated investments in research and development, leading to advancements in technology, manufacturing processes, and scalability, further driving the growth of the allogeneic stem cells market.

Side Effects Associated with Allogeneic Stem Cell Transplantation will Hamper the Growth of the Market

The side effects associated with allogeneic stem cell transplantation are a major factor hampering the market growth. Graft-versus-Host Disease (GVHD) is a common complication of allogeneic stem cell transplantation, where the transplanted immune cells attack the recipient&#39;s body tissues. It can range from mild to severe and can affect multiple organs, leading to significant morbidity and mortality.

Infusion reactions can occur during the transplantation process, where the recipient may experience symptoms such as fever, chills, allergic reactions, or respiratory distress. These reactions are typically managed with appropriate medications, but they can still impact patient experience and treatment outcomes

<h2>&nbsp;</h2>

<h3>Allogeneic Stem Cells Market&nbsp; Segment Analysis</h3>

The global allogeneic stem cells market is segmented based on product, cell origin, application, and region.

The Cord Blood Stem Cells Segment Accounted for Approximately 34.9% of the Allogeneic Stem Cells Market Share

The market is anticipated to grow throughout the projection due to cord blood stem cells. Cord blood contains a higher concentration of hematopoietic stem cells compared to other sources, such as bone marrow or peripheral blood. These hematopoietic stem cells are crucial for the replenishment of blood cells, making cord blood a valuable resource for hematopoietic stem cell transplantation (HSCT) in treating various blood disorders, immune deficiencies, and genetic diseases.

Cord blood stem cells have a higher tolerance for HLA mismatches, reducing the risk of graft-versus-host disease (GvHD). This compatibility advantage allows for a broader donor pool and increases the likelihood of finding suitable matches for transplantation, contributing to the popularity of cord blood stem cells.

For instance, on April 17, 2023, Gamida Cell Ltd., a cell therapy pioneer working to turn cells into powerful therapeutics, announced that the U.S. Food and Drug Administration (FDA) has approved Gamida Cell&rsquo;s allogeneic cell therapy, Omisirge (omidubicel-onlv), for use in adult and pediatric patients 12 years and older with hematologic malignancies planned for umbilical cord blood transplantation following myeloablative conditioning to reduce the time to neutrophil recovery and the incidence of infection.

<img src="https://lh3.googleusercontent.com/GWD0Pb2A-78SvJgBzQiWmBzx6s5bMxIBgLYUgFPVbYibEqqvESohf18OQHs9gTXUx8UY_6cWkFeU0erdujHEFYRa60JJ0huXyhNiTbr35xS7ls7e59u2X6m4sZoID_umz-b7EbwLuCNR9a3ifKp6pw" style="height:336px; width:576px" />

Source: DataM Intelligence Analysis (2023)

<h2>&nbsp;</h2>

<h3>Global Allogeneic Stem Cells Market&nbsp; Geographical Penetration</h3>

North America Accounted for Approximately 41.6% of the Market Share in 2022, Owing to the Well-Developed Healthcare Infrastructure and Presence of Major Players&nbsp;

North America has a robust and advanced healthcare infrastructure, including hospitals, clinics, research institutions, and regulatory bodies. This infrastructure supports the development, manufacturing, and distribution of progesterone products, ensuring efficient market access and availability.

The region is home to several prominent pharmaceutical companies and biotechnology firms involved in the production and marketing of progesterone products. These companies have strong research and development capabilities, extensive distribution networks, and established brand recognition, enabling them to capture a significant market share.

<img src="https://lh5.googleusercontent.com/LnXKO3YqlwyMW-MmFr1X1JA-3qZoYgcV9qroRHShiZ3IP3DmfowrhioZbnLGGNKK84Iqnuh39leWr1CjK5J-tIb5-oXvRYP2nZbiqueWtpzDSBlf9I0S-aLWrJQjqBdzsT_wtSw7NsiSMdFdZ-E13Q" style="height:336px; width:576px" />

Source: DataM Intelligence Analysis (2023)

<h2>&nbsp;</h2>

<h3>Allogeneic Stem Cells Market&nbsp;Companies</h3>

The major global players in the allogeneic stem cells market include STEMCELL Technologies Inc., Lineage Cell Therapeutics Inc., Takeda Pharmaceutical Co. Ltd., Biosolution Co. Ltd., Cynata Therapeutics Ltd., JCR Pharmaceuticals Co. Ltd., MEDIPOST Co. Ltd., MiMedx Group Inc., Osiris Therapeutics Inc., and Stempeutics Research Pvt. Ltd and others.

&nbsp;

<h3>COVID-19 Impact on&nbsp;Allogeneic Stem Cells Market&nbsp;</h3>

Russia Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global allogeneic stem cells market. The conflict can disrupt supply chains for allogeneic stem cell products, including stem cell sources, processing facilities, and transportation routes. Restrictions on trade and logistical challenges led to delays or difficulties in procuring and delivering allogeneic stem cells, affecting market availability.

By Product

<ul>
	<li>Adult Stem Cells</li>
	<li>Human Embryonic Stem Cells</li>
	<li>Induced Pluripotent Stem Cells</li>
</ul>

By Cell Origin

<ul>
	<li>Bone Marrow Stem Cells</li>
	<li>Peripheral Blood Stem Cells</li>
	<li>Cord Blood Stem Cells</li>
	<li>Others</li>
</ul>

By Application

<ul>
	<li>Cardiovascular Disorders</li>
	<li>Immunological Disorders</li>
	<li>Cancers</li>
	<li>Musculoskeletal Disorders</li>
	<li>Others</li>
</ul>

By Region

<ul>
	<li>North America
	<ul>
		<li>The U.S.</li>
		<li>Canada</li>
		<li>Mexico</li>
	</ul>
	</li>
	<li>Europe
	<ul>
		<li>Germany</li>
		<li>The U.K.</li>
		<li>France</li>
		<li>Spain</li>
		<li>Italy</li>
		<li>Rest of Europe</li>
	</ul>
	</li>
	<li>South America
	<ul>
		<li>Brazil</li>
		<li>Argentina</li>
		<li>Rest of South America</li>
	</ul>
	</li>
	<li>Asia-Pacific
	<ul>
		<li>China</li>
		<li>India</li>
		<li>Japan</li>
		<li>Australia</li>
		<li>Rest of Asia-Pacific</li>
	</ul>
	</li>
	<li>Middle East and Africa</li>
</ul>

Key Developments

<ul>
	<li>On June 12, 2023, StemCyte, a California-based regenerative therapeutics company announced that it signed a cooperation agreement with a leading US cell therapy company that is developing allogeneic genetically modified CAR-NK cells using umbilical cord blood. StemCyte has agreed to supply the necessary cellular raw materials for allogeneic cell therapy product development worldwide.&nbsp;</li>
	<li>On January 09, 2023, Calidi Biotherapeutics, Inc., a clinical-stage biotechnology company that is pioneering the development of allogeneic cell-based delivery of oncolytic viruses, and First Light Acquisition Group (&ldquo;FLAG&rdquo;), a special purpose acquisition company organized to acquire or merge with one or more businesses, announced that they have entered into a definitive merger agreement to create a public company focused on developing oncolytic viral therapies with stem cell-based delivery platforms to treat a wide range of cancers with significant unmet needs.&nbsp;</li>
</ul>

Why Purchase the Report?

<ul>
	<li>To visualize the global allogeneic stem cells market segmentation based on product, cell origin, application, and region, as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of allogeneic stem cells market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as Excel consisting of key products of all the major players.</li>
</ul>

The global allogeneic stem cells market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2024

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

For more Biotechnology related reports, <a href="https://www.datamintelligence.com/industry-verticals/biotechnology">please click here</a>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Product</li>
		<li>Snippet by Cell Origin</li>
		<li>Snippet by Application</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Rising Demand for Regenerative Medicines</li>
				<li>Increasing Awareness and Acceptance of Stem Cell Therapies</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Side Effects Associated with Stem Cells Transplantation&nbsp;</li>
			</ol>
			</li>
			<li>Opportunity
			<ol>
				<li>Technological Advancements in Allogeneic Stem Cells Transplantations</li>
			</ol>
			</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&rsquo;s 5 Force Analysis&nbsp;&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID-19</li>
			<li>Scenario During COVID-19</li>
			<li>Scenario Post COVID-19&nbsp;</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During the Pandemic</li>
		<li>Manufacturer&rsquo;s Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Product</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Attractiveness Index, By Product</li>
		</ol>
		</li>
		<li>Adult Stem Cells *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Human Embryonic Stem Cells</li>
		<li>Induced Pluripotent Stem Cells</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Cell Origin</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Origin</li>
			<li>Market Attractiveness Index, By Cell Origin</li>
		</ol>
		</li>
		<li>Bone Marrow Stem Cells *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Peripheral Blood Stem Cells</li>
		<li>Cord Blood Stem Cells</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Application</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Attractiveness Index, By Application</li>
		</ol>
		</li>
		<li>Cardiovascular Disorders *
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Immunological Disorders</li>
		<li>Cancers</li>
		<li>Musculoskeletal Disorders</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Origin</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>The U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Origin</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>The U.K.</li>
				<li>France</li>
				<li>Spain</li>
				<li>Italy</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Origin</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Origin</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Rest of Asia-Pacific</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Product</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Cell Origin</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Application&nbsp;</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>STEMCELL Technologies Inc. *
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>Lineage Cell Therapeutics Inc.</li>
		<li>Takeda Pharmaceutical Co. Ltd.</li>
		<li>Biosolution Co. Ltd.</li>
		<li>Cynata Therapeutics Ltd.</li>
		<li>JCR Pharmaceuticals Co. Ltd.</li>
		<li>MEDIPOST Co. Ltd.</li>
		<li>MiMedx Group Inc.</li>
		<li>Osiris Therapeutics Inc.</li>
		<li>Stempeutics Research Pvt. Ltd.(*LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

<h3>List of Tables&nbsp;</h3>

Table 1 Global Allogeneic Stem Cells Market Value, By Product, 2023, 2027 &amp; 2031 (US$ Billion)

Table 2 Global Allogeneic Stem Cells Market Value, By Cell Origin, 2023, 2027 &amp; 2031 (US$ Billion)

Table 3 Global Allogeneic Stem Cells Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Billion)

Table 4 Global Allogeneic Stem Cells Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Billion)

Table 5 Global Allogeneic Stem Cells Market Value, By Product, 2023, 2027 &amp; 2031 (US$ Billion)

Table 6 Global Allogeneic Stem Cells Market Value, By Product, 2022-2031 (US$ Billion)

Table 7 Global Allogeneic Stem Cells Market Value, By Cell Origin, 2023, 2027 &amp; 2031 (US$ Billion)

Table 8 Global Allogeneic Stem Cells Market Value, By Cell Origin, 2022-2031 (US$ Billion)

Table 9 Global Allogeneic Stem Cells Market Value, By Application, 2023, 2027 &amp; 2031 (US$ Billion)

Table 10 Global Allogeneic Stem Cells Market Value, By Application, 2022-2031 (US$ Billion)

Table 11 Global Allogeneic Stem Cells Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Billion)

Table 12 Global Allogeneic Stem Cells Market Value, By Region, 2022-2031 (US$ Billion)

Table 13 North America Allogeneic Stem Cells Market Value, By Product, 2022-2031 (US$ Billion)

Table 14 North America Allogeneic Stem Cells Market Value, By Cell Origin, 2022-2031 (US$ Billion)

Table 15 North America Allogeneic Stem Cells Market Value, By Application, 2022-2031 (US$ Billion)

Table 16 North America Allogeneic Stem Cells Market Value, By Country, 2022-2031 (US$ Billion)

Table 17 South America Allogeneic Stem Cells Market Value, By Product, 2022-2031 (US$ Billion)

Table 18 South America Allogeneic Stem Cells Market Value, By Cell Origin, 2022-2031 (US$ Billion)

Table 19 South America Allogeneic Stem Cells Market Value, By Application, 2022-2031 (US$ Billion)

Table 20 South America Allogeneic Stem Cells Market Value, By Country, 2022-2031 (US$ Billion)

Table 21 Europe Allogeneic Stem Cells Market Value, By Product, 2022-2031 (US$ Billion)

Table 22 Europe Allogeneic Stem Cells Market Value, By Cell Origin, 2022-2031 (US$ Billion)

Table 23 Europe Allogeneic Stem Cells Market Value, By Application, 2022-2031 (US$ Billion)

Table 24 Europe Allogeneic Stem Cells Market Value, By Country, 2022-2031 (US$ Billion)

Table 25 Asia-Pacific Allogeneic Stem Cells Market Value, By Product, 2022-2031 (US$ Billion)

Table 26 Asia-Pacific Allogeneic Stem Cells Market Value, By Cell Origin, 2022-2031 (US$ Billion)

Table 27 Asia-Pacific Allogeneic Stem Cells Market Value, By Application, 2022-2031 (US$ Billion)

Table 28 Asia-Pacific Allogeneic Stem Cells Market Value, By Country, 2022-2031 (US$ Billion)

Table 29 Middle East &amp; Africa Allogeneic Stem Cells Market Value, By Product, 2022-2031 (US$ Billion)

Table 30 Middle East &amp; Africa Allogeneic Stem Cells Market Value, By Cell Origin, 2022-2031 (US$ Billion)

Table 31 Middle East &amp; Africa Allogeneic Stem Cells Market Value, By Application, 2022-2031 (US$ Billion)

Table 32 STEMCELL Technologies Inc.: Overview

Table 33 STEMCELL Technologies Inc.: Product Portfolio

Table 34 STEMCELL Technologies Inc.: Key Developments

Table 35 Lineage Cell Therapeutics Inc.: Overview

Table 36 Lineage Cell Therapeutics Inc.: Product Portfolio

Table 37 Lineage Cell Therapeutics Inc.: Key Developments

Table 38 Takeda Pharmaceutical Co. Ltd.: Overview

Table 39 Takeda Pharmaceutical Co. Ltd.: Product Portfolio

Table 40 Takeda Pharmaceutical Co. Ltd.: Key Developments

Table 41 Biosolution Co. Ltd.: Overview

Table 42 Biosolution Co. Ltd.: Product Portfolio

Table 43 Biosolution Co. Ltd.: Key Developments

Table 44 Cynata Therapeutics Ltd.: Overview

Table 45 Cynata Therapeutics Ltd.: Product Portfolio

Table 46 Cynata Therapeutics Ltd.: Key Developments

Table 47 JCR Pharmaceuticals Co. Ltd.: Overview

Table 48 JCR Pharmaceuticals Co. Ltd.: Product Portfolio

Table 49 JCR Pharmaceuticals Co. Ltd.: Key Developments

Table 50 MEDIPOST Co. Ltd.: Overview

Table 51 MEDIPOST Co. Ltd.: Product Portfolio

Table 52 MEDIPOST Co. Ltd.: Key Developments

Table 53 MiMedx Group Inc.: Overview

Table 54 MiMedx Group Inc.: Product Portfolio

Table 55 MiMedx Group Inc.: Key Developments

Table 56 Osiris Therapeutics Inc.: Overview

Table 57 Osiris Therapeutics Inc.: Product Portfolio

Table 58 Osiris Therapeutics Inc.: Key Developments

Table 59 Stempeutics Research Pvt. Ltd.: Overview

Table 60 Stempeutics Research Pvt. Ltd.: Product Portfolio

Table 61 Stempeutics Research Pvt. Ltd.: Key Developments

<h3>List of Figures</h3>

Figure 1 Global Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 2 Global Allogeneic Stem Cells Market Share, By Product, 2022 &amp; 2031 (%)

Figure 3 Global Allogeneic Stem Cells Market Share, By Cell Origin, 2022 &amp; 2031 (%)

Figure 4 Global Allogeneic Stem Cells Market Share, By Application, 2022 &amp; 2031 (%)

Figure 5 Global Allogeneic Stem Cells Market Share, By Region, 2022 &amp; 2031 (%)

Figure 6 Global Allogeneic Stem Cells Market Y-o-Y Growth, By Product, 2022-2031 (%)

Figure 7 Adult Stem Cells Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 8 Human Embryonic Stem Cells Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 9 Induced Pluripotent Stem Cells Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 10 Others Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 11 Global Allogeneic Stem Cells Market Y-o-Y Growth, By Cell Origin, 2022-2031 (%)

Figure 12 Bone Marrow Stem Cells Cell Origin in Global Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 13 Peripheral Blood Stem Cells Cell Origin in Global Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 14 Cord Blood Stem Cells Cell Origin in Global Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 15 Others Cell Origin in Global Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 16 Global Allogeneic Stem Cells Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 17 Cardiovascular Disorders Application in Global Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 18 Immunological Disorders Application in Global Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 19 Cancers Application in Global Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 20 Musculoskeletal Disorders Application in Global Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 21 Others Application in Global Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 22 Global Allogeneic Stem Cells Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 23 North America Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 24 Asia-Pacific Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 25 Europe Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 26 South America Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 27 Middle East and Africa Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 28 North America Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 29 North America Allogeneic Stem Cells Market Share, By Product, 2022 &amp; 2031 (%)

Figure 30 North America Allogeneic Stem Cells Market Share, By Cell Origin, 2022 &amp; 2031 (%)

Figure 31 North America Allogeneic Stem Cells Market Share, By Application, 2022 &amp; 2031 (%)

Figure 32 North America Allogeneic Stem Cells Market Share, By Country, 2022 &amp; 2031 (%)

Figure 33 South America Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 34 South America Allogeneic Stem Cells Market Share, By Product, 2022 &amp; 2031 (%)

Figure 35 South America Allogeneic Stem Cells Market Share, By Cell Origin, 2022 &amp; 2031 (%)

Figure 36 South America Allogeneic Stem Cells Market Share, By Application, 2022 &amp; 2031 (%)

Figure 37 South America Allogeneic Stem Cells Market Share, By Country, 2022 &amp; 2031 (%)

Figure 38 Europe Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 39 Europe Allogeneic Stem Cells Market Share, By Product, 2022 &amp; 2031 (%)

Figure 40 Europe Allogeneic Stem Cells Market Share, By Cell Origin, 2022 &amp; 2031 (%)

Figure 41 Europe Allogeneic Stem Cells Market Share, By Application, 2022 &amp; 2031 (%)

Figure 42 Europe Allogeneic Stem Cells Market Share, By Country, 2022 &amp; 2031 (%)

Figure 43 Asia-Pacific Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 44 Asia-Pacific Allogeneic Stem Cells Market Share, By Product, 2022 &amp; 2031 (%)

Figure 45 Asia-Pacific Allogeneic Stem Cells Market Share, By Cell Origin, 2022 &amp; 2031 (%)

Figure 46 Asia-Pacific Allogeneic Stem Cells Market Share, By Application, 2022 &amp; 2031 (%)

Figure 47 Asia-Pacific Allogeneic Stem Cells Market Share, By Country, 2022 &amp; 2031 (%)

Figure 48 Middle East &amp; Africa Allogeneic Stem Cells Market Value, 2022-2031 (US$ Billion)

Figure 49 Middle East &amp; Africa Allogeneic Stem Cells Market Share, By Product, 2022 &amp; 2031 (%)

Figure 50 Middle East &amp; Africa Allogeneic Stem Cells Market Share, By Cell Origin, 2022 &amp; 2031 (%)

Figure 51 Middle East &amp; Africa Allogeneic Stem Cells Market Share, By Application, 2022 &amp; 2031 (%)

Figure 52 STEMCELL Technologies Inc.: Financials

Figure 53 Lineage Cell Therapeutics Inc.: Financials

Figure 54 Takeda Pharmaceutical Co. Ltd.: Financials

Figure 55 Biosolution Co. Ltd.: Financials

Figure 56 Cynata Therapeutics Ltd.: Financials

Figure 57 JCR Pharmaceuticals Co. Ltd.: Financials

Figure 58 MEDIPOST Co. Ltd.: Financials

Figure 59 MiMedx Group Inc.: Financials

Figure 60 Osiris Therapeutics Inc.: Financials

Allogeneic Stem Cells Market Size, Share, Industry, Forecast and outlook (2024-2031)

Stem Cell Therapy for Diabetes and Related Conditions Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 16

Starting from

Bone Marrow Transplantation Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 April 12

Starting from

Cancer Stem Cells Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 08

Starting from

Stem Cell Banking Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 10

Starting from

Cancer Stem Cell Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 21

Starting from

Animal Stem Cell Therapy Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 23

Starting from